BMKDF (Biomark Diagnostics) Ending Cash Position : $0.06 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Biomark Diagnostics Ending Cash Position?

Biomark Diagnostics's Ending Cash Position for the quarter that ended in Dec. 2024 was $0.06 Mil.

Biomark Diagnostics's quarterly Ending Cash Position declined from Jun. 2024 ($0.10 Mil) to Sep. 2024 ($0.03 Mil) but then increased from Sep. 2024 ($0.03 Mil) to Dec. 2024 ($0.06 Mil).

Biomark Diagnostics's annual Ending Cash Position declined from Mar. 2022 ($0.30 Mil) to Mar. 2023 ($0.05 Mil) but then increased from Mar. 2023 ($0.05 Mil) to Mar. 2024 ($0.12 Mil).

Biomark Diagnostics Ending Cash Position Historical Data

The historical data trend for Biomark Diagnostics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomark Diagnostics Ending Cash Position Chart

Biomark Diagnostics Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Ending Cash Position

Get a 7-Day Free Trial

0.44

0.70

0.30

0.05

0.12

Biomark Diagnostics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															0.23	0.12	0.10	0.03	0.06

Biomark Diagnostics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Biomark Diagnostics's Ending Cash Position for the fiscal year that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.053	+	0.063
	=	0.12

Biomark Diagnostics's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.024	+	0.038
	=	0.06

Biomark Diagnostics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Biomark Diagnostics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomark Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomark Diagnostics Inc (OTCPK:BMKDF) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

20B:Germany BUX:Canada

Address

130 - 3851 Shell Road, Richmond, BC, CAN, V6X 2W2

Website

https://www.biomarkdiagnostics.com

Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early cancer treatment. Its research and development are focused on the role that metabolomics plays in early cancer detection. The company's objective is to commercialize its inventive technology. and strive to increase the predictive accuracy in early-stage cancer detection.

Biomark Diagnostics Headlines

No Headlines